Document:

EXHIBIT 10.9

 

SHAREHOLDER
SUPPORT AGREEMENT AND DEED

 

This SHAREHOLDER SUPPORT AGREEMENT
AND DEED (this “Agreement”) is made and entered into as of May 26, 2022, by and among ECARX Holdings Inc., an
exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), COVA Acquisition
Corp., an exempted company limited by shares incorporated under the laws of the Cayman Islands (“SPAC”), and certain
Persons listed on Schedule A hereto (each, a “Shareholder” and collectively, the “Shareholders”).

 

WHEREAS, capitalized
terms used but not otherwise defined in this Agreement shall have the meanings ascribed thereto in the Agreement and Plan of Merger (the
 “Merger Agreement”) dated as of the date hereof, entered into by and among the Company, Ecarx Temp Limited, an exempted
company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger
Sub 1”), Ecarx&Co Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands and a
direct wholly owned subsidiary of the Company (“Merger Sub 2”), and SPAC, pursuant to which, among other things, (i) Merger
Sub 1 will merge with and into SPAC, with SPAC surviving the First Merger as a wholly owned subsidiary of the Company (the “First
Merger”), and (ii) SPAC will merge with and into Merger Sub 2, with Merger Sub 2 surviving the Second Merger as a wholly
owned subsidiary of the Company (the “Second Merger” and together with the First Merger, collectively, the “Mergers”);

 

WHEREAS, each Shareholder
is, as of the date of this Agreement, the beneficial and sole legal owner of such number of Ordinary Shares and Preferred Shares of the
Company set forth opposite such Shareholder’s name on Schedule A hereto (such Ordinary Shares and Preferred Shares being
collectively referred to herein as the “Owned Shares”; and the Owned Shares and any other Company Shares, Company Ordinary
Shares or any securities convertible into or exercisable or exchangeable for Company Shares or Company Ordinary Shares, as the case may
be, acquired by such Shareholder after the date of this Agreement and during the term of this Agreement, including upon exercise of Company
Options, being collectively referred to herein as the “Subject Shares” of such Shareholder); and

 

WHEREAS, as a condition
to their willingness to enter into the Merger Agreement, the Company and SPAC have requested that the Shareholders enter into this Agreement.

 

NOW, THEREFORE,
in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below, and intending
to be legally bound hereby, the parties hereto agree as follows:

 

     

     

    

 

Article I

 

Representations
and Warranties of THE SHAREHOLDERS

 

Each Shareholder hereby represents and warrants
to the Company and SPAC as follows:

 

Section 1.1             Corporate
Organization. Such Shareholder has been duly formed and is validly existing and in good standing under the Laws of the place of its
incorporation or establishment and has the requisite power and authority to own, lease or operate its assets and properties and to conduct
its business as it is now being conducted.

 

Section 1.2             Due
Authorization. Such Shareholder has all requisite power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the consummation
of the transactions contemplated hereby have been duly and validly authorized and no other corporate or equivalent proceeding on the part
of such Shareholder is necessary to authorize the execution and delivery of this Agreement or such Shareholder’s performance hereunder
or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by such Shareholder
and, assuming due authorization and execution by each other party hereto, constitutes a legal, valid and binding obligation of such Shareholder,
enforceable against such Shareholder in accordance with its terms, subject to the Enforceability Exceptions.

 

Section 1.3             Governmental
Authorities; Consents. No consent of or with any Governmental Authority on the part of such Shareholder is required to be obtained
or made in connection with the execution, delivery or performance by such Shareholder of this Agreement or the consummation by such Shareholder
of the transactions contemplated hereby, other than (a) applicable requirements, if any, of the Securities Act, the Exchange Act,
and/ or any state “blue sky” securities Laws, and the rules and regulations thereunder and (b) where the failure
to obtain or make such consents or to make such filings or notifications would not reasonably be expected to prevent, impede or, in any
material respect, delay or adversely affect the execution and performance by such Shareholder of its obligations under this Agreement
or the consummation of the transactions contemplated hereby.

 

Section 1.4             No-Conflict.
The execution, delivery and performance by such Shareholder of this Agreement do not and will not (a) contravene or conflict with
or violate any provision of, or result in the breach of the Organizational Documents of such Shareholder, (b) contravene or conflict
with or result in a violation of any provision of any Law or Governmental Order binding upon or applicable to such Shareholder or any
of its properties or assets, (c) violate, conflict with, result in a breach of any provision of or the loss of any benefit under,
constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination
or acceleration of, or a right of termination, cancellation, modification, acceleration or amendment under, accelerate the performance
required by, any of the terms, conditions or provisions of any Contract to which such Shareholder is a party, or (d) result in the
creation or imposition of any Encumbrance on any properties or assets of such Shareholder, except in the case of each of clauses (b) through
(d) that do not, and would not reasonably be expected to, prevent, impede or, in any material respect, delay or adversely affect
the performance by such Shareholder of its obligations under this Agreement or the consummation of the transactions contemplated hereby.

 

    2

     

    

 

Section 1.5             Owned
Shares. Such Shareholder is the beneficial and sole legal owner of the Owned Shares, and all such Owned Shares are owned by such Shareholder
free and clear of all liens or encumbrances, other than liens or encumbrances pursuant to this Agreement, the other Transaction Documents,
the Organizational Documents of the Company, the Investors Rights Agreement and any applicable securities Laws. Such Shareholder does
not legally or beneficially own any shares of the Company other than the Owned Shares. Such Shareholder has the sole right to vote the
Owned Shares (to the extent such securities have voting rights), and none of the Owned Shares is subject to any voting trust or other
agreement, arrangement or restriction with respect to the voting of the Owned Shares, except as contemplated by this Agreement, the Investors
Rights Agreement and the Company Charter.

 

Section 1.6             Acknowledgement.
Such Shareholder understands and acknowledges that each of the Company and SPAC is entering into the Merger Agreement in reliance upon
such Shareholder’s execution and delivery of this Agreement. Such Shareholder has received a copy of the Merger Agreement and is
familiar with the provisions of the Merger Agreement.

 

Section 1.7             Absence
of Litigation. As of the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge
of such Shareholder, threatened against, such Shareholder or any of such Shareholder’s properties or assets (including such Shareholder’s
Owned Shares) that could reasonably be expected to prevent, delay or impair the ability of such Shareholder to perform its obligations
hereunder or to consummate the transactions contemplated hereby.

 

Section 1.8             Adequate
Information. Such Shareholder is a sophisticated shareholder and has adequate information concerning the business and financial condition
of SPAC and the Company to make an informed decision regarding this Agreement and the transactions contemplated by the Merger Agreement
and has independently and without reliance upon SPAC or the Company and based on such information as such Shareholder has deemed appropriate,
made its own analysis and decision to enter into this Agreement. Such Shareholder acknowledges that SPAC and the Company have not made
and do not make any representation or warranty, whether express or implied, of any kind or character except as expressly set forth in
this Agreement. Such Shareholder acknowledges that the agreements contained herein with respect to the Subject Shares held by such Shareholder
are irrevocable and shall only terminate pursuant to Section 5.2 hereof.

 

Section 1.9             Restricted
Securities. Such Shareholder understands that the Company Ordinary Shares to be held by it immediately following the consummation
of the Mergers will be “restricted securities” under applicable U.S. federal and state securities Laws and, if such Shareholder
is an affiliate of the Company, “control securities” as such term is used under Rule 144 promulgated under the Securities
Act, and that, pursuant to these Laws, such Shareholder may be required to hold such Company Ordinary Shares indefinitely unless (a) they
are registered with the SEC and qualified by state authorities, or (b) an exemption from such registration and qualification requirements
is available, and that any certificates or book entries representing the Company Ordinary Shares shall contain a legend to such effect.

 

    3

     

    

 

Article II

 

Representations
and Warranties of SPAC

 

SPAC hereby represents and warrants to the Company
and each Shareholder as follows:

 

Section 2.1             Corporate
Organization. SPAC is an exempted company duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands
and has the requisite corporate power and authority to own, lease or operate its assets and properties and to conduct its business as
it is now being conducted.

 

Section 2.2             Due
Authorization. SPAC has all requisite corporate power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the consummation
of the transactions contemplated hereby have been duly and validly authorized and approved by the board of directors of SPAC and no other
corporate or equivalent proceeding on the part of SPAC is necessary to authorize the execution and delivery of this Agreement or SPAC’s
performance hereunder or to consummate the transactions contemplated hereby (except that the SPAC Shareholders’ Approval is a condition
to the respective obligations of each party to the Merger Agreement to consummate the Mergers). This Agreement has been duly and validly
executed and delivered by SPAC and, assuming due authorization and execution by each other party hereto, constitutes a legal, valid and
binding obligation of SPAC, enforceable against SPAC in accordance with its terms, subject to the Enforceability Exceptions.

 

Section 2.3             No-Conflict.
Subject to obtaining the SPAC Shareholders’ Approval, the execution, delivery and performance by SPAC of this Agreement and the
consummation of the transactions by SPAC contemplated hereby do not and will not (a) contravene or conflict with or violate any provision
of, or result in the breach of the Organizational Documents of SPAC, (b) contravene or conflict with or result in a violation of
any provision of any Law, Permit or Governmental Order binding upon or applicable to SPAC or any of its properties or assets, (c) violate,
conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with
notice or lapse of time or both, would constitute a default) under, or result in the termination or acceleration of, or a right of termination,
cancellation, modification, acceleration or amendment under, accelerate the performance required by, any of the terms, conditions or provisions
of any Contract to which SPAC is a party, or (d) result in the creation or imposition of any Encumbrance upon any of the properties
or assets of SPAC (including the Trust Account), except in the case of each of clauses (b) through (d) that do not, and would
not reasonably be expected to prevent, impede or, in any material respect, delay or adversely affect the performance by SPAC of its obligations
under this Agreement or the consummation of the transactions contemplated hereby.

 

    4

     

    

 

Article III

 

Representations
and Warranties of the Company

 

The Company hereby represents and warrants to
SPAC and each Shareholder as follows:

 

Section 3.1             Corporate
Organization. The Company is an exempted company duly incorporated, is validly existing and is in good standing under the Laws of
the Cayman Islands and has the requisite corporate power and authority to own, lease or operate its assets and properties and to conduct
its business as it is now being conducted.

 

Section 3.2             Due
Authorization. The Company has the requisite corporate power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the consummation
of the transactions contemplated hereby have been duly authorized by the Company Board, and no other corporate proceeding on the part
of the Company is necessary to authorize this Agreement or the Company’s performance hereunder (except that the Company Shareholders’
Approval is a condition to the respective obligations of each party to the Merger Agreement to consummate of the Transactions). This Agreement
has been duly and validly executed and delivered by the Company and, assuming due and valid authorization, execution and delivery by each
other party hereto, constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its
terms, subject to the Enforceability Exceptions.

 

Section 3.3             No-Conflict.
The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated
hereby do not and will not, (a) contravene or conflict with, violate any provision of, trigger shareholder rights that have not been
duly waived under, or result in the breach of the Organizational Documents of the Company or any of its Subsidiaries, (b) contravene
or conflict with or constitute a violation of any provision of any Law, Material Permit or Governmental Order binding upon or applicable
to the Company or any of its Subsidiaries or any of their respective properties or assets, (c) violate, conflict with, result in
a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time or
both, would constitute a default) under, or result in the termination or acceleration of, or a right of termination, cancellation, modification,
acceleration or amendment under, accelerate the performance required by, any of the terms, conditions or provisions of any Contracts to
which the Company is a party, or (d) result in the creation or imposition of any Encumbrance on any properties or assets or Equity
Security of the Company or any of its Subsidiaries (other than any Permitted Encumbrance), except in the case of clauses (b) through
(d) above that do not, and would not reasonably be expected to, prevent, impede or, in any material respect, delay or adversely affect
the performance by the Company of its obligations under this Agreement or the consummation of the transactions contemplated hereby.

 

    5

     

    

 

Article IV

 

Agreement
to Vote; Certain Other Covenants of THE ShareholderS

 

Each Shareholder covenants and agrees during the
term of this Agreement as follows:

 

Section 4.1             Agreement
to Vote.

 

(a)            In
Favor of the Company Shareholders’ Approval. From the date of this Agreement until the date of termination of this Agreement,
at any meeting of the Company Shareholders called to seek the Company Shareholders’ Approval, including any extraordinary general
meeting (as defined in the Company Charter), or at any adjournment thereof or postponement thereof, or in connection with any written
consent of the Company Shareholders or in any other circumstances upon which a vote, consent or other approval with respect to the Transactions,
the Merger Agreement or any other Transaction Documents is sought, such Shareholder shall (i) if a meeting is held, appear at such
meeting in person or by proxy or otherwise cause the Subject Shares to be counted as present at such meeting for purposes of establishing
a quorum, and (ii) vote or cause to be voted (including by proxy, withholding class vote and/or written consent, if applicable)
the Subject Shares in favor of granting the Company Shareholders’ Approval or, if there are insufficient votes in favor of granting
the Company Shareholders’ Approval, in favor of the adjournment or postponement of such meeting of the Company Shareholders to
a later date.

 

(b)            Against
Other Transactions. From the date of this Agreement until the date of termination of this Agreement, at any meeting of the Company
Shareholders or at any adjournment or postponement thereof, or in connection with any written consent of the Company Shareholders or in
any other circumstances upon which such Shareholder’s vote, consent or other approval is sought, such Shareholder shall (i) if
a meeting is held, appear at such meeting in person or by proxy or otherwise cause the Subject Shares to be counted as present at such
meeting for purposes of establishing a quorum, (ii) vote (or cause to be voted) the Subject Shares (including by proxy, withholding
class vote and/or written consent, if applicable) against (w) any business combination agreement, merger agreement or merger, scheme
of arrangement, business combination, consolidation, combination, sale of substantial assets, reorganization, recapitalization, dissolution,
liquidation or winding up of or by the Company or any public offering of any Equity Securities of the Company (other than the Merger Agreement
and the Transactions), (x) other than in connection with the Transactions, any Company Acquisition Proposal, (y) allowing the
Company to execute or enter into, any agreement related to a Company Acquisition Proposal other than in connection with the Transactions,
and (z) any amendment of Organizational Documents of the Company or entering into any agreement or agreement in principle or other
proposal or transaction involving the Company or any of its Subsidiaries, which amendment, agreement or other proposal or transaction
would be reasonably likely to in any material respect impede, interfere with, delay or attempt to discourage, frustrate the purposes of,
result in a breach by the Company of, prevent or nullify any provision of the Merger Agreement or any other Transaction Document, the
Transactions or change in any manner the voting rights of any class of the Company’s share capital.

 

    6

     

    

 

(c)            Revoke
Other Proxies. Such Shareholder represents and warrants that any proxies or powers of attorney heretofore given in respect of the
Subject Shares that may still be in effect are not irrevocable, and such proxies or powers of attorney have been or are hereby revoked.

 

Section 4.2             No
Transfer. From the date of this Agreement until the date of termination of this Agreement, such Shareholder shall not, directly or
indirectly, (i) (a) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option, right or warrant
to purchase or otherwise transfer, dispose of or agree to transfer or dispose of, directly or indirectly, or establish or increase a put
equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, and
the rules and regulations of the SEC promulgated thereunder, with respect to any Subject Share, (b) enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Shares, whether
any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) publicly announce any intention
to effect any transaction specified in clause (a) or (b) (the actions specified in clauses (a) to (c), collectively,
 “Transfer”), (ii) grant any proxies or powers of attorney or enter into any voting arrangement, whether by proxy,
voting agreement, voting trust, voting deed or otherwise (including pursuant to any loan of Subject Shares), or enter into any other agreement,
with respect to any Subject Shares, in each case, other than as set forth in this Agreement or any Transaction Documents, (iii) take
any action that would reasonably be expected to make any representation or warranty of such Shareholder herein untrue or incorrect, or
would reasonably be expected to have the effect of preventing or disabling such Shareholder from performing its obligations hereunder,
or (iv) commit or agree to take any of the foregoing actions. Notwithstanding the foregoing, such Shareholder may make Transfers
of the Subject Shares (x) pursuant to this Agreement, (y) upon the consent of the Company and SPAC, and (z) by virtue of
such Shareholder’s Organizational Documents upon liquidation or dissolution of such Shareholder; provided, further,
that in the case of clause (z), the transferee will not be required to assume voting obligations if the transferee’s assumption
of such obligations would violate any applicable Laws, including any securities Laws, or would reasonably be expected to materially delay
or impede the Registration Statement or Proxy Statement being declared effective under the Securities Act. Any action attempted to be
taken in violation of the preceding sentence will be null and void.

 

Section 4.3             Waiver
of Anti-Dilution Protection. Such Shareholder hereby waives, and agrees not to exercise, assert or claim, to the fullest extent permitted
by applicable Law, the anti-dilution protection pursuant to the Company Charter in connection with the Transactions.

 

    7

     

    

 

Section 4.4             No
Redemption. Such Shareholder irrevocably and unconditionally agrees that, from the date hereof and until the termination of this Agreement,
such Shareholder shall not elect to cause the Company to redeem any Subject Shares now or at any time legally or beneficially owned by
such Shareholder, or submit or surrender any of its Subject Shares for redemption, in each case pursuant to the Company Charter.

 

Section 4.5             New
Securities. In the event that prior to the Closing (i) any Company Shares or other securities are issued or otherwise distributed
to such Shareholder, including, without limitation, pursuant to any share dividend or distribution, or any change occurs in any of the
Company Shares or other share capital of the Company by reason of any share subdivision, recapitalization, combination, reverse share
split, consolidation, exchange of shares or the like, (ii) such Shareholder acquires legal or beneficial ownership of any Company
Shares after the date of this Agreement, including upon exercise of options, or (iii) such Shareholder acquires the right to vote
or share in the voting of any Company Shares after the date of this Agreement (collectively, the “New Securities”),
the term “Subject Shares” shall be deemed to refer to and include such New Securities (including all such share dividends
and distributions and any securities into which or for which any or all of the Subject Shares may be changed or exchanged into).

 

Section 4.6             Shareholders’
Consent, Authorization or Approval. Each Shareholder hereby irrevocably agrees and confirms that, insofar as such Shareholder’s
consent, authorization or approval is required in respect of or in connection with the transactions contemplated by the Merger Agreement
and the other Transaction Documents, including without limitation, the matters as set out in items (c) and (e) of Part I
and item (a) of Part IV of Exhibit B of the Investors Rights Agreement and as may be required by Article 18 (Variation
of Rights of Shares), Article 137 (Amendment of the Memorandum and Articles) and Section 4.3.1 of Schedule A (Protective
Provisions) of the Company Charter, such Shareholder hereby grants, provides and gives such consent, authorization or approval, and
all specific resolutions that may be required to have been adopted by such Shareholder or class of shareholders in connection with the
transactions contemplated by the Merger Agreement and the other Transaction Documents are hereby deemed adopted and approved by such Shareholder.
To the extent a director appointed by such Shareholder will not serve as a director of the Company after the Closing, upon request of
the Company, such Shareholder shall deliver a notice to the Company to remove such director or cause such director to execute and deliver
a resignation letter to the Company providing for such director’s resignation from the board of directors of the Company at the
First Effective Time.

 

Section 4.7             Existing
Investors Rights Agreement. Each of the Shareholders and the Company hereby agrees that, in accordance with the terms thereof, (i) the
Investors Rights Agreement, (ii) any rights of such Shareholder under the Investors Rights Agreement (including, for the avoidance
of doubt, any registration rights of such Shareholder with respect to any Company Shares thereunder) and (iii) any rights under any
other agreement providing for redemption rights, put rights, purchase rights or other similar rights not generally available to the shareholders
of the Company, shall be terminated effective as of the First Effective Time, and thereupon shall be of no further force or effect, without
any further action on the part of any of the Shareholders or the Company, and neither the Company, the Shareholders, nor any of their
respective affiliates or subsidiaries shall have any further rights, duties, liabilities or obligations thereunder and each Shareholder
and the Company hereby releases in full any and all claims with respect thereto with effect on and from the First Effective Time.

 

    8

     

    

 

Section 4.8             Additional
Matters. Each Shareholder shall, from time to time, (i) execute and deliver, or cause to be executed and delivered, such additional
or further consents, documents and other instruments as the Company or SPAC may reasonably request for the purpose of effectively consummating
the transactions contemplated by this Agreement, the Merger Agreement and the other Transaction Documents and (ii) refrain from exercising
any veto right, consent right or similar right (whether under the Organizational Documents of the Company or the Cayman Companies Act)
which would prevent, impede or, in any material respect, delay or adversely affect the consummation of the Transactions.

 

Section 4.9             Acquisition
Proposals; Confidentiality. Such Shareholder shall be bound by and comply with Section 5.5 (Acquisition Proposals and Alternative
Transactions) and Section 10.14 (Confidentiality) of the Merger Agreement (and any relevant definitions contained in any
such sections) as if (a) such Shareholder was an original signatory to the Merger Agreement with respect to such provisions, and
(b) each reference to “the Company” contained in Section 5.5 of the Merger Agreement and “Affiliates”
contained in Section 10.14 of the Merger Agreement shall also refer to such Shareholder.

 

Section 4.10           Lock-Up
Provisions.

 

(a)            Subject
to the exceptions set forth herein, during the applicable Lock-Up Period (as defined below), such Shareholder agrees not to, without the
prior written consent of the Company Board, Transfer any Locked-Up Shares held by it. The foregoing limitations shall remain in full force
and effect for a period of six (6) months from and after the Closing (such period, the “Lock-Up Period”) with
respect to all the Locked-Up Shares. For purpose of this Section 4.10, “Locked-Up Shares” means any Company Ordinary
Shares that are held by such Shareholder immediately after the First Effective Time and any Company Ordinary Shares acquired by such Shareholder
upon the exercise of Company Options.

 

(b)           The
restrictions set forth in Section 4.10(a) (the “Lock-Up Restrictions”) shall not apply to:

 

(i)            transfers
by such Shareholder to (A) any shareholder, partner or member of such Shareholder via dividend or share repurchase as part of a distribution,
or (B) any Person that is an affiliate of such Shareholder;

 

(ii)           transfers
by virtue of the Laws of the state of such Shareholder’s organization and such Shareholder’s Organizational Documents upon
dissolution of such Shareholder;

 

    9

     

    

 

(iii)          pledges
of any Locked-Up Shares to a financial institution that create a mere security interest in such Locked-Up Shares pursuant to a bona fide
loan or indebtedness transaction so long as such Shareholder continues to control the exercise of the voting rights of such pledged Locked-Up
Shares (as well as any foreclosures on such pledged Locked-Up Shares so long as the transferee in such foreclosure agrees to become a
party to this Agreement and be bound by all obligations applicable to such Shareholder, provided that such agreement shall only
take effect in the event that the transferee takes possession of the Locked-Up Shares as a result of foreclosure);

 

(iv)          transfers
of any Company Ordinary Shares acquired as part of the Permitted Financing or Subsequent Equity Financing;

 

(v)           transactions
relating to Company Ordinary Shares or other securities convertible into or exercisable or exchangeable for Company Ordinary Shares acquired
in open market transactions after the Closing, provided that no such transaction is required to be, or is, publicly announced (whether
on Form 4, Form 5 or otherwise, other than a required filing on Schedule 13F, 13G or 13G/A) during the applicable Lock-Up Period;

 

(vi)          the
exercise of any options to purchase Company Ordinary Shares (which exercises may be effected on a cashless basis to the extent the instruments
representing such options or warrants permit exercises on a cashless basis);

 

(vii)         transfers
to the Company to satisfy tax withholding obligations pursuant to the Company’s equity incentive plans or arrangements;

 

(viii)        the
establishment, at any time after the Closing, by a Shareholder of a trading plan providing for the sale of Company Ordinary Shares that
meets the requirements of Rule 10b5-1(c) under the Exchange Act (a “Trading Plan”); provided, however,
that no sales of Locked-Up Shares, shall be made by such Shareholder pursuant to such Trading Plan during the applicable Lock-Up Period
and no public announcement or filing is voluntarily made regarding such plan during the applicable Lock-Up Period; and

 

(ix)          transfers
made in connection with a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s
shareholders having the right to exchange their Company Ordinary Shares for cash, securities or other property subsequent to the Closing
Date;

 

provided, however, that in the case of
clauses (i) through (iv), these permitted transferees must enter into a written agreement, in substantially the form of this
Agreement, agreeing to be bound by the Lock-Up Restrictions and shall have the same rights and benefits under this Agreement. For purposes
of this paragraph, “affiliate” shall have the meaning set forth in Rule 405 under the Securities Act of 1933, as amended.

 

    10

     

    

 

(c)            For
the avoidance of doubt, such Shareholder shall retain all of its rights as a shareholder of the Company during the Lock-Up Period, including
the right to vote any Locked-Up Shares or receive any dividends or distributions thereon.

 

(d)            In
furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the Locked-Up Securities,
are hereby authorized to decline to make any transfer of securities if such Transfer would constitute a violation or breach of the Lock-Up
Restrictions.

 

Article V

 

General
Provisions

 

Section 5.1             Mutual
Release.

 

(a) Shareholder
Release. Such Shareholder, on its own behalf and on behalf of each of its Affiliates (other than the Company or any of the
Company’s Subsidiaries) and each of its and their successors, assigns and executors (each, a “Shareholder
Releasor”), effective as at the First Effective Time, shall be deemed to have, and hereby does, irrevocably,
unconditionally, knowingly and voluntarily release, waive, relinquish and forever discharge the Company, SPAC, their respective
Subsidiaries and each of their respective successors, assigns, heirs, executors, officers, directors, partners, managers and
employees (in each case in their capacity as such) (each, a “Shareholder Releasee”), from (x) any and all
obligations or duties the Company, SPAC or any of their respective Subsidiaries has prior to or as of the First Effective Time to
such Shareholder Releasor or (y) all claims, demands, Liabilities, defenses, affirmative defenses, setoffs, counterclaims,
actions and causes of action of whatever kind or nature, whether known or unknown, which any Shareholder Releasor has prior to or as
of the First Effective Time, against any Shareholder Releasee arising out of, based upon or resulting from any Contract,
transaction, event, circumstance, action, failure to act or occurrence of any sort or type, whether known or unknown, and which
occurred, existed, was taken, permitted or begun prior to the First Effective Time (except in the event of fraud on the part of a
Shareholder Releasee); provided, however, that nothing contained in this Section 5.1 shall release, waive,
relinquish, discharge or otherwise affect the rights or obligations of any party (i) arising under this Agreement, the Merger
Agreement, the other Transaction Documents or the Company’s Organizational Documents, (ii) for indemnification or
contribution, in any Shareholder Releasor’s capacity as an officer or director of the Company, (iii) arising under any
then-existing insurance policy of the Company, or (iv) for any claim for fraud.

 

    11

     

    

 

(b)            Company
Release. Each of the Company, SPAC and their respective Subsidiaries and each of its and their successors, assigns and executors (each,
a “Company Releasor”), effective as at the First Effective Time, shall be deemed to have, and hereby does, irrevocably,
unconditionally, knowingly and voluntarily release, waive, relinquish and forever discharge such Shareholder and its respective successors,
assigns, heirs, executors, officers, directors, partners, members, managers and employees (in each case in their capacity as such) (each,
a “Company Releasee”), from (x) any and all obligations or duties such Company Releasee has prior to or as of
the First Effective Time to such Company Releasor or (y) all claims, demands, Liabilities, defenses, affirmative defenses, setoffs,
counterclaims, actions and causes of action of whatever kind or nature, whether known or unknown, which any Company Releasor has, may
have or might have or may assert now or in the future, against any Company Releasee arising out of, based upon or resulting from any Contract,
transaction, event, circumstance, action, failure to act or occurrence of any sort or type, whether known or unknown, and which occurred,
existed, was taken, permitted or begun prior to the First Effective Time (except in the event of fraud on the part of a Company Releasee);
provided, however, that nothing contained in this Section 5.1(b) shall release, waive, relinquish, discharge
or otherwise affect the rights or obligations of any party (i) arising under this Agreement, the Merger Agreement or the other Transaction
Documents or (ii) for any claim for fraud.

 

Section 5.2             Termination.
This Agreement shall terminate upon the earlier of:

 

(a)            the
Closing, provided, however, that upon such termination, (i)  Section 4.8, this Section 5.1,
Section 5.4 and Section 5.7 shall survive indefinitely; and (ii) Section 4.10 and Section 5.3
shall survive until the date on which none of the Company, such Shareholder or any holder of a Locked-Up Share (as defined below) has
any rights or obligations hereunder; and

 

(b)           the
termination of the Merger Agreement in accordance with its terms, and upon such termination, no party shall have any liability hereunder
other than for its actual fraud or willful and material breach of this Agreement prior to such termination.

 

Section 5.3             Legends.
The Company shall remove, and shall cause to be removed (including by causing its transfer agent to remove), any legends, marks, stop-transfer
instructions or other similar notations pertaining to the lock-up arrangements herein from the book-entries evidencing any Locked-Up Shares
at the time any such share is no longer subject to the Lock-Up Restrictions (any such Locked-Up Share, a “Free Share”),
and shall take all such actions (and shall cause to be taken all such actions) necessary or proper to cause the Free Shares to be consolidated
under the CUSIP(s) and/or ISIN(s) applicable to the unrestricted Company Ordinary Shares so that the Free Shares are in a like
position. Any holder of a Locked-Up Share is an express third-party beneficiary of this Section 5.3 and entitled to enforce
specifically the obligations of the Company set forth in this Section 5.3 directly against the Company.

 

Section 5.4             Notice.
All general notices, demands or other communications required or permitted to be given or made hereunder shall be in writing and delivered
personally or sent by courier or sent by registered post or sent by electronic mail to the Company and SPAC in accordance with Section 10.3
of the Merger Agreement and to each Shareholder at its address set forth on Schedule A hereto (or at such other address or email
address as a party may from time to time notify the other parties by like notice).

 

    12

     

    

 

Section 5.5             Entire
Agreement; Amendment. This Agreement constitutes the entire agreement among the parties hereto relating to the subject matter hereof
and the transactions contemplated hereby and supersedes any other agreements, whether written or oral, that may have been made or entered
into by or between the parties hereto or any of their respective Subsidiaries relating to the subject matter hereof or the transactions
contemplated hereby. This Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to
any particular provision, except by a written instrument executed by all parties hereto.

 

Section 5.6             Assignment.
Other than in connection with the Transfer of any Subject Shares or Locked-Up Shares in accordance with the terms of this Agreement, which
shall not be deemed to be an assignment of this Agreement or the rights or obligations hereunder, no party hereto shall assign this Agreement
or any part hereof without the prior written consent of the other parties hereto and any such transfer without prior written consent shall
be void. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
permitted successors and assigns.

 

Section 5.7             Governing
Law. This Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Agreement (whether based
on law, in equity, in contract, in tort or any other theory) or the negotiation, execution, performance or enforcement of this Agreement,
shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to the principles of conflicts
of laws that would otherwise require the application of the law of any other state.

 

Section 5.8             Enforcement.
The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto shall be entitled
to seek an injunction or injunctions to prevent breaches of this Agreement and to specific enforcement of the terms and provisions of
this Agreement, in addition to any other remedy to which any party is entitled at law or in equity. In the event that any Action shall
be brought in equity to enforce the provisions of this Agreement, no party shall allege, and each party hereby waives the defense, that
there is an adequate remedy at law, and each party agrees to waive any requirement for the securing or posting of any bond in connection
therewith.

 

Section 5.9             Counterparts
This Agreement may be executed in two or more counterparts (any of which may be delivered by electronic transmission), each of which shall
constitute an original, and all of which taken together shall constitute one and the same instrument. Delivery by email to counsel for
the other parties of a counterpart executed by a party shall be deemed to meet the requirements of the previous sentence.

 

[Signature pages follow]

 

    13

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	COVA Acquisition Corp.	 
	 	 
	By:	 /s/ Jun Hong Heng	 
	Name: Jun Hong Heng	 
	
    Title: Chief Executive Officer

    
	 

 

	In the presence of:	 
	Witness	 
	 	 
	Signature: 	/s/ Karanveer Dhillon	 
	Print Name: Karanveer Dhillon	 

 

[Signature Page to Company
Shareholder Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	ECARX Holdings Inc.	 
	 	 
	By:	/s/ Ziyu Shen	 
	Name:	 Ziyu Shen	 
	Title:	Director	 

 

	In the presence of:	 
	Witness	 
	 	 
	Signature:	/s/ Xiangru Song	 
	Print Name: 	Xiangru Song	 

 

[Signature Page to Company
Shareholder Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	Fu&Li Industrious Innovators Limited	 
	 	 
	By:	/s/ Shufu Li	 
	Name: 	Shufu Li	 
	Title:	Director	 

 

	In the presence of:	 
	Witness	 
	 	 
	Signature:	/s/ Weilie Ye	 
	Print Name: 	Weilie Ye	 

 

[Signature Page to Company
Shareholder Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	Jie&Hao Holding Limited	 
	 	 
	By:	/s/ Ziyu Shen	 
	Name: 	Ziyu Shen

	 
	Title:	Director	 

 

	In the presence of:	 
	Witness	 
	 	 
	Signature:	/s/ Xiangru Song	 
	Print Name: 	Xiangru Song	 

 

[Signature Page to Company
Shareholder Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	SHINE LINK VENTURE LIMITED	 
	 	 
	By:	For and on behalf on T Proteus Limited	 
		/s/ Catherine Yim	 
	 	/s/ Edward Gumbley	 
	Name: T Proteus Limited	 
	Title: Director	 
	 	 
	In the presence of:	 
	Witness	 

 
	Signature:	 /s/ Claudia Ng	                                    

Print Name: 
Claudia Ng 

 

[Signature Page to Company
Shareholder Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	Baidu (Hong Kong) Limited	 
	 	 
	By:	/s/ Herman Yu	 
	Name: Herman Yu	 
	Title: Director	 
	 	 
	In the presence of:	 
	Witness	 

 
	Signature:	 /s/ Maonan Wei	                                     

Print Name:  Maonan Wei

 

[Signature Page to Company
Shareholder Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	Suzhou Xiangcheng Venture Capital Co., Ltd.	 
	 	 
	By:	/s/ Chenling Tao	 
	Name: Chenling Tao	 
	Title: Legal Representative	 
	 	 
	In the presence of:	 
	Witness	 

 

	Signature:	 /s/ Yuewen Gu	                                     

Print Name:   Yuewen Gu

 

[Signature Page to Company
Shareholder Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have hereunto
caused this Agreement to be duly executed as of the date hereof as a Deed.

 

EXECUTED AND DELIVERED AS A DEED for and on behalf of:

 

	Suzhou Huanxiu Lake Yihao Investment Co., Ltd.	 
	 	 
	By:	/s/ Dongjun Li	 
	Name: Dongjun Li	 
	Title: Legal Representative	 
	 	 
	In the presence of:	 
	Witness	 

 

	Signature:	 /s/ Wenlong He	                                     

Print Name:  Wenlong HeExhibit 10.10

 

ECARX HOLDINGS INC.

 

2021 Restrictive Share Incentive Plan (Trust)

 

(Effective from December 1, 2021)

 

     

     

    

 

ECARX HOLDINGS INC.

  

2021 Restrictive Share Incentive Plan (Trust)

  

1.       Purpose.
The 2021 Restrictive Share Incentive Plan (Trust) (hereinafter referred to as the “Plan”) is intended to attract and retain
the best talents on the market, to motivate the Company’s or its related entities’ senior management members, core experts,
employees of level P5-2 or higher, and those who have made outstanding contribution to the Company’s technological breakthroughs
and created commercial value for the Company (Hereinafter the “Eligible Incentive Parties”).

 

2.       Definition.
In this Plan and Grant Agreement, the following terms shall apply, except where otherwise defined in a separate grant agreement. If a
certain term is otherwise defined in a separate grant agreement, then such definition shall replace that set out in Article 2 hereof.

 

(a) “Grantee” means
an Eligible Incentive Party to whom a grant is made hereunder.

 

(b) “Disability”
means the situation in which a Grantee becomes unable to perform his/her function and duty for no less than ninety (90) consecutive days
due to any medically assessable physiological or mental impairment. A Grantee shall not be deemed to be disabled unless he/she has provided
the Administrator with evidence of his/her impairment which is reasonably satisfactory as determined by the Administrator at its discretion.

 

     

     

    

 

(c) “Continuous Service”
means the rendering of service by a Grantee for the Company or its related entities in the capacity of an Eligible Incentive Party which
is not suspended or terminated. If pursuant to the applicable law of the jurisdiction where the Grantee is, the service of a Grantee must
not be effectively terminated unless a prior notice is given, then the Continuous Service of the Grantee shall terminate at the time when
he/she actually ceases to provide service for the Company or its related entities, notwithstanding any requirement for notification period
which must be satisfied under applicable law in order to effectively terminate the service of the Grantee. When the Continuous Service
of a Grantee has actually terminated, or the subject for which the Grantee renders service is no longer a related entity, then the Continuous
Service of the Grantee shall be deemed to have been terminated. Under the following conditions, the Continuous Service of a Grantee shall
not be deemed to have been terminated: (i) approved leave; (ii) transfer of an Eligible Incentive Party between the Company, any of its
related entities or any successor; or (iii) any change in capacity notwithstanding which the Grantee continues being employed by the Company
or its related entity in the capacity of an Eligible Incentive Party(unless otherwise provided in the Grant Agreement). Approved leave
includes sick leave, leave for military service or any other private leave of absence approved.

 

(d) “Director”
means a member of the board of directors of the Company or any related entity.

 

(e) “Board of Directors”
means the board of directors of the Company.

 

(f) “Split-Up Transaction”
means a transaction in which the Company distributes all or a part of the shares in any of its subsidiaries to its shareholders.

 

(g) “Senior Management
Members” mean any individual hired by the Company or its related entity who holds a senior managerial position such as [CEO,
COO, CFO, CTO and Strategic Advisor];

 

     

     

    

 

(h) “Company”
means ECARX HOLDINGS INC., a company incorporated under the laws of Cayman Islands, or any successor-in-interest of this Plan under
the circumstance where a Sale in Entirety of the Company occurs.

 

(i) A “Sale in Entirety
of the Company” means any of the transactions mentioned below (as reasonably determined by the Administrator):

 

(i)       Merger
of the Company with or into, acquisition of it by, or other business combination between it and any other entity, in which the Company
is not the surviving entity, or any other single transaction or a series of transactions in which the shareholders of the Company existing
immediately before such transaction or transactions cease to own the majority of voting rights in the surviving entity immediately after
the completion of the transaction, except for a transaction of which the main purpose is to change the Company’s place of incorporation;

 

(ii)       the
sale, transfer, granting of an exclusive license in respect of and otherwise disposing of all or substantially all the assets of the Company,
its subsidiaries, related companies;

 

(iii)       completion
of liquidation or winding up by the Company;

 

(iv)       a
reverse takeover or a series of related transactions leading to a reverse takeover where the Company is the surviving
entity(including but not limited to a takeover bid prior to a reverse takeover), except the situations mentioned below which are
deemed by the Administrator not constituting a Sale in Entirety or a series of related transactions leading to the Sale in Entirety:
(A) the ordinary shares issued and outstanding prior to the takeover are converted into or exchanged for other properties (whether
it being securities, cash or other form of properties) pursuant to the takeover, or (B) shares issued and outstanding representing
fifty percent (50%) of the Company’s voting rights are transferred to one or several entities other than the entity which owns
such shares prior to the takeover or a series of related transactions leading to the takeover; or

 

     

     

    

 

(v)       except
the situation in which any entity or a group related to such entity (other than the Company or an employee benefit plan initiated by the
Company) acquires the beneficial ownership of fifty percent (50%) or more of the Company’s outstanding voting shares, which, as
the Administrator deems, does not constitute a Sale in Entirety of the Company or a series of transactions leading to a Sale in Entirety.

 

(j) “Shares”
mean the ordinary shares of the Company.

 

(k) “Administrator”
means Mr. Shen Ziyu or any committee or individual appointed by him to administer this plan.

 

(l) “Related Parties”
mean: (a) as to an entity, any other entity which directly or indirectly controls the first-mentioned entity, which is controlled
by the first-mentioned entity or which is under common control with the first-mentioned entity; or(b) in the case of an individual, a
 “related party” shall include his/her parents, spouse, children(and the spouse of his/her children, if any), siblings (and
the spouse of his/her siblings), or other lineal relatives, or any entity which is controlled by any of the individuals mentioned above.

 

(m) “Related Entities”
mean any parent company, subsidiary or related party of the Company, and any company, corporation, partnership, limited liability company
or other entity which is directly or indirectly beneficially owned by the Company, its parent company, subsidiary or related party.

 

     

     

    

 

(n) “Core Experts”
mean any individual employed by the Company or its related entity, who holds a core R&D position in the Company or its related entity,
such as [Chief Scientist/Senior Researcher/Chief Engineer].

 

(o) “Succession”
means that, as at the time when a Sale in Entirety of the Company occurs: (i) the Company expressly acknowledges the grant, or (ii) the
successor involved in the Sale in Entirety of the Company or the parent company thereof expressly indicates that (rather than solely a
mandatory requirement of law) it would inherit the contractual obligations under a grant, such inheritance may give rise to appropriate
adjustment of the number and type of shares to be issued by the successor or its parent company under the grant, the grant price and conditions
for disposal of the shares, provided that such adjustment shall at least retain the indemnification elements under the grant which are
determined pursuant to the instrument giving consent to the inheritance of the grant as at the time when the Sale in Entirety of the Company
occurs.

 

(p) “Plan”
means this 2021 Restrictive Share Incentive Plan (Trust).

 

(q) “Change in Control”
means (as reasonably determined by the Administrator) a change in the ownership or control of the Company resulting from the situations
mentioned below: any entity or a group related to such entity directly or indirectly acquires the beneficial ownership of fifty percent
(50%) or more of the outstanding voting shares of the Company (except for acquisition by the Company, the employee benefit plan initiated
by the Company or a related party of the Company), which acquisition is done through directly making a tender offer or exchange offer
to the Company’s shareholders, and in which the majority of directors who are not related parties of the offer or have advised the
shareholders not to accept such offer.

 

     

     

    

 

(r) “Control”,
as to a specific entity, means the power and authority (whether or not exercised) to directly or indirectly give instructions on such
entity’s business, management or decision-making through the ownership of voting shares, by contract or otherwise. Such power or
authority shall be conclusively deemed to exist if the following conditions are met: beneficially owning fifty percent (50%) or more of
the voting power represented by all the votable shares at the general meeting of such entity, or having the power to control the majority
of the members of the entity’s board of directors.

 

(s) “Parent Company”
means any company (other than the “Company” ) on a continuous company chain of which the Company forms the end, and in which
every company (other than the “Company”) owns or controls fifty percent (50%) or more interest in the aggregate voting power
represented by the various classes of shares of another company on the company chain. Any company which meets the criteria for a parent
company after the entry into effect of this Plan shall be deemed to be a parent company from the date on which such criteria are met.

 

(t) “Ordinary Shares”
mean the ordinary shares of the Company with par value of US$0.000005 each, the par value per share may be adjusted proportionately to
reflect dividend distribution, share split or similar transactions.

 

(u) “Applicable Laws”
mean laws and regulations relating to this Plan and Grant made hereunder, including: applicable laws, statutes, regulations, federal
securities laws, state corporation laws and state securities laws, the rules of any applicable share exchange or national trading systems,
as well as the laws, regulations, orders or rules of any jurisdiction which apply to a grant made to residents in such jurisdiction or
the Grantee.

 

     

     

    

 

(v) “Initial Public
Offering” means the Company’s undertaking to offer and issue any of its securities(or securities of its successor) to
the general public for the first time in pursuance of: (a) registration statements submitted in accordance with the Securities Act of
1933 and subsequent amendment thereto, or(b) in the case that such securities shall be listed for trading on other internationally recognized
share exchange, the securities law of the jurisdiction where the share exchange is located, which apply to the issuance of securities.

  

(w) “Grant”
means the grant of restrictive share made hereunder. For the avoidance of doubt, as the shares intended to be issued in connection with
the grant made hereunder are actually held through a trust platform, a grant made in pursuance hereof shall be fulfilled through the appointment
of the trust platform and the related trust beneficiary by the settlor of trust and through distribution of interest in the trust.

 

(x) “Grant Agreement”
means a written agreement executed between the Company and a Grantee evidencing the grant, and the subsequent amendment made thereto.

 

(y) “Substitution”
means the replacement of a grant made hereunder pursuant to the Sale in Entirety of the Company, with comparable shares, share incentive
or cash incentive plan of the Company, its successor (if applicable) or its parent company, where the comparable shares, share incentive
or cash incentive plan has retained the indemnification element existing in the grant as at the time when the Sale in Entirety of the
Company occurs, and has provided the Grantee with the same (or more favorable) conditions for the disposal of shares as compared with
the original grant. The “Comparability” of a grant shall be determined by the Administrator, whose decision shall be final,
binding and conclusive.

 

(z) “Restrictive Shares”
mean shares issued to a Grantee hereunder for a certain consideration (if any), which are subject to terms governing the transfer,
repossession and confiscation of such shares and other restrictive terms as may be imposed by the Administrator.

 

     

     

    

 

(aa) “Trust”
means a trust created for the purpose of this plan.

 

(bb) “Settlor of Trust”
means Mr. Shen Ziyu.

 

(cc) “Trust Platform”
is a collective term referring to BRAND MARKET INTERNATIONAL LIMITED which is one hundred percent (100%) controlled by the Trust and SHINE
LINK VENTURE LIMITED which is one hundred percent (100%) controlled by BRAND MARKET INTERNATIONAL LIMITED (i.e. the Trust actually owns
shares in the Company through indirectly owning one hundred percent (100%) shares in SHINE LINK VENTURE LIMITED).

 

(dd) “Entities”
mean any individual, corporation, partnership, limited partnership, limited liability company, institution, joint venture, estate, trust,
unincorporated organization, association, enterprise, firm, corporation not-for-profit, entity, governmental and regulatory body, or entity
of any other kind or nature.

 

(ee) “Subsidiary”,
as to a specific entity, means (i) any entity, (x) in respect of which the specific entity owns more than fifty percent (50%) shares or
other interest granting voting power for the election of directors of such entity, or (y) more than fifty percent (50%) of whose profit
or capital is directly or indirectly owned by such specific entity (or indirectly through one or more of its subsidiaries); (ii) any entity,
all or a part of whose assets are consolidated with the net income of the specific entity and recorded in the financial statements of
the specific entity for the purpose of financial reporting in accordance with applicable accounting standards; or (iii) any entity, in
respect of which the specific entity has the power to give instructions directly or indirectly regarding its business or decision-making.

 

     

     

    

 

3.       Shares
under this Plan 

  

(a) The aggregate number of
shares intended for issuance in connection with a grant made hereunder shall not exceed the number of the entire ordinary shares held
by the Trust Platform (which, subject to the provisions of Article 10 below, may be adjusted proportionately in order to reflect dividend
distributions, share split or similar transactions).

 

(b) If a grant (or part of a
grant) is confiscated, cancelled or withdrawn (whether or not voluntarily), any shares corresponding with such grant shall not be deemed
to be outstanding shares for the purpose of computing the maximum number of shares issuable hereunder. The shares actually issued hereunder
by virtue of a grant shall not be returned and be used as shares for the purpose hereof, and shall not be used as shares for future issuance
hereunder, unless the relevant shares are confiscated, cancelled or withdrawn by the Company pursuant to this Plan, in which case, such
shares may be used in connection with future grants made hereunder.

  

4.       Plan
Administration 

 

(a) Plan Administrator 

 

(i)       Administration.
This Plan shall be administered by the Administrator. The Administrator may authorize one or more senior managers or directors to make
a grant, and may impose restrictions on such grant from time to time at its discretion.

 

(ii)       Binding
force. Any grant made or interpretation of any grant agreement made by the Administrator in respect or in pursuance of this Plan,
as well as all decisions and elections made by the Administrator in respect of this Plan shall be final, binding and conclusive.

 

     

     

    

 

(b) Powers of the Administrator.
Subject to applicable laws and the terms hereof (including any other rights conferred upon the Administrator hereunder), the Administrator
shall exercise the following rights at its discretion:

 

(i)       To
select and determine, from time to time, the list of individuals who shall be eligible for a grant hereunder as Eligible Incentive Parties;

  

(ii)       to
determine whether to make a grant in pursuance hereof and the scope of such grant;

 

(iii)       to
determine the type or number of grant, and to determine the number of shares or amount of consideration which corresponds with each grant
made hereunder;

 

(iv)       to
approve the standard text of a grant agreement to be used in connection herewith, and to amend the terms thereunder;

 

(v)       to
determine or amend the terms and conditions under which any grant shall be made hereunder(including but not limited to the Share Grant
Notice and the conditions for disposal of such shares under the grant agreement and the grant price);

 

(vi)       to
amend the terms of any grant made hereunder in respect of which issuance has been made, provided that, without the Grantee’s
written consent, no amendment shall be made which has a material adverse effect on the rights of the Grantee under a grant in
respect of which issuance has been made;

 

     

     

    

 

(vii)       to
interpret the terms of this Plan and grant made hereunder, including but not limited to a Share Grant Notice or Grant Agreement made in
accordance herewith;

 

(viii)       to
request the Grantee to provide a statement or evidence, guaranteeing that the money used by him/her for paying the price of any grant
is lawfully obtained and remitted from the jurisdiction where the Grantee resides in accordance with applicable law;

 

(ix)       to
take other actions that the Administrator deems appropriate, which do not contravene the terms of this Plan and applicable laws.

  

(c) Indemnification.
In addition to other rights of indemnification which may be available to board members or employees of the Company or its related
entities, the board members or employees who are authorized to represent the Administrator or the Company in administering this Plan
shall, to the extent permitted by applicable law and approved by the Administrator, receive protection and indemnification from the
Company (on an after-tax basis), be indemnified against all actual and necessary expenses including attorney’s fee (arising
from the defense or appeal of any claim, investigation, action or other proceedings to which such individuals are made a party as a
result of their action or omission to act pursuant to this Plan or the grant made hereunder), as well as all amounts paid by such
individuals as a result of settlement (if the Company agrees to settle) or suit, investigation, action, litigation or other
proceeding, unless in such claim, investigation, action, suit or other proceedings, such individuals are held to be legally liable
as a result of bad faith or willful misconduct. The above-mentioned indemnification is subject to the condition that, within thirty
(30) days from the occurrence of any such claim, investigation, action, suit or other proceedings, such individuals shall have
provided the Company with a written notice, thereby affording the Company an opportunity to defend, at its own expense, such claim,
investigation, action, suit or proceedings.

 

     

     

    

 

 

5.         Eligibility

 

Authorization may be granted
to Eligible Incentive Parties. Unless otherwise decided by the Manager, the Eligible Incentive Parties who have been granted Authorization
will no longer participate in the Company’s other equity or option incentive Plans.

 

6.         Authorization-related
Terms

 

(a) Authorization Category.
Under this Plan, the Manager has the right to grant Restrictive Shares of the Company to Eligible Incentive Parties that do not conflict
with the terms of this Plan. Notwithstanding the foregoing stipulations, since the Shares used for authorized issuance under this Plan
have been actually held through the Trust Platform, the Company Shares granted under this Plan will be reflected in the corresponding
share of the Trust Platform’s right to benefit distribution.

 

(b) Designation of Authorization.
Each Authorization shall be specified in the Grant Agreement.

 

(c) Authorization
Conditions. Within the limitations of the terms of this Plan, the Manager has the right to determine the terms and conditions of
each Authorization, including but not limited to conditions for the disposal of Restrictive Shares, recovery provisions, forfeiture
provisions, payment methods at the time of Authorization settlement, contingent payment arrangements, and conditions for
satisfaction of any performance. Each Authorization shall be subject to the terms of the specific Grant Agreement. Manager may
independently set Authorization criteria, and the number or value of Authorizations a Grantee can obtain depends on the extent to
which they meet those Authorization criteria. The granting criteria formulated by the Manager may include, but are not limited to,
the Grantee’s post category, post level, personal performance, etc. These granting criteria may apply to the Company and/or
Related Entity.

 

     

     

    

 

(d) Independent Program.
For the purpose of granting a particular form of Authorization to one or more categories of Grantees, the Manager may establish one or
more separate programs under this Plan, and the terms and conditions of which may be determined by the Manager from time to time.

 

(e) Authorization Validity
Period. Unless otherwise expressly provided in the grant notice and/or Grant Agreement, each Authorization shall be valid for a period
not exceeding [five (5) years] from the date of Authorization.

 

(f) Transferability of Authorization
and/or Shares.

 

(i)        Except
as otherwise provided in this Plan or the Grant Agreement, the Grantee shall not sell, assign, delegate, mortgage, pledge or otherwise
dispose of the Authorizations it has accepted and/or any Shares (including the right to distribute benefits obtained from the Trust Platform)
acquired under the Authorizations without the approval of the Manager.

 

     

     

    

 

(ii)       After
the Company completes the IPO (Initial Public Offering) and releases the restrictions, subject to Applicable Laws, the requirements of
the underwriters (including but not limited to the requirements regarding the lock-up period) and the provisions of this Plan, the Grantee
may dispose of the Shares under the Authorization through secondary market sales. Following the completion of the Company’s IPO
and the release of the restrictions, the Grantee may sell the Shares under the Authorization in the following two circumstances: (x) the
Grantee’s Continuous Service with the Company or Related Entity has been five (5) years, then he/she has the right to sell all or
part of the Shares under the Authorization at any subsequent time; or (y) the Grantee’s Continuous Service with the Company or Related
Entity is less than five (5) years, for each full one (1) year of Continuous Service of the Grantee in the Company or the Related Entity,
his/her cumulative right to sell the Shares under the Authorization does not exceed the total number of Shares he/her has acquired under
the Authorization * twenty percent (20%) * the complete number of his/her Continuous Service year number. If the Grantee intends to sell
the Shares under any Authorization, the Grantee may give written notice to the Company to sell all or part (as the case may be) of the
Shares he/she has acquired under the Authorization, and the Company will receive such written notice within [five (5) trading days] after
the notification, and when the stock exchange allows, it will deal with the request for the sale of Shares by the Grantee, and have the
right to choose: (x) to dispose of the relevant Shares by instructing the Trust Platform, and to distribute the relevant income to the
Grantee; or (y) to distribute the relevant Shares to the individual securities account designated by the Grantee by instructing the Trust
Platform. After the income distribution is completed, the Grantee is no longer the beneficiary of the Trust for all or part of the disposed
Authorization and the Shares thereunder, and the Manager has the right to directly instruct the Settlor of Trust to order the Trust Platform
and its related Trusts to change the beneficiary share or list accordingly without the cooperation of the Grantee to sign any further
documents. Any tax incurred by the Grantee on the disposal of any Shares under the Authorization pursuant to this Article shall be borne
by the Grantee.

 

     

     

    

 

(iii)      In
the event that the Continuous Service of the Grantee is terminated due to the death of the Grantee, the Authorization and Shares that
the Grantee may retain under Article 9(a) shall be inherited and distributed in accordance with the will of the Grantee or the Applicable
Laws, and the following Subjects may obtain the reserved Authorization and Shares : (x) one (and only one) authorized beneficiary Subject
named by the deceased Grantee; or (y) if there is no effectively named beneficiary Subject, the legal representative of the deceased Grantee,
or the authorized Subject according to the will of the Grantee or stipulated by the Applicable Laws are the beneficiary subject. The terms
of the Authorization are binding on the executors, managers, heirs, successors and assigns (collectively “Heirs”) of the deceased
Grantee.

 

(g) Date of Authorization.
In any event, the date on which an Authorization is granted shall be the date on which the Manager decides to grant the Authorization
or such other date as the Manager may designate. The date of Authorization shall be expressly agreed in the grant notice and/or Grant
Agreement.

 

7.         Grant
Price, Consideration and Taxes of Authorization

 

(a) Grant Price. The grant price, if any,
for an Authorization shall be determined by the Manager and expressly agreed in the grant notice and/or Grant Agreement. The Grantee shall
pay the grant price in full within the validity period of the Authorization, and the overdue payment or failure to pay in full shall be
deemed to be a waiver of the Authorization by the Grantee with regard to that part of the unpaid grant price.

 

(b) Consideration.
Within the limits of Applicable Laws, the consideration paid for Shares issued as a result of the purchase Authorization, including
the method of payment, shall be determined by the Manager. Considering that the Settlor of Trust has completed the actual capital
contribution obligation to the Company through the Trust Platform, the grant consideration shall be paid to the Settlor of Trust.
Except for any other kind of consideration that the Manager may determine, the Authorization consideration shall be paid in
cash.

 

     

     

    

 

(c) Tax. The Grantee
shall be responsible for all taxes related to the Authorization and the acceptance, transfer and disposal of Shares. Shares under this
Plan (represented as the right to distribute the Trust interests) shall not be transferred to any Grantee until the Grantee has made arrangements
acceptable to the Manager for the fulfillment of the income tax and payroll tax payment obligations to be undertaken in accordance with
the requirements of Applicable Laws. Once the Shares are delivered, the Company and/or the Related Entity and/or Trust Platform for which
the Grantee serves shall have the right to withhold or collect from the Grantee an amount sufficient to meet the aforesaid tax obligations.
At the time of grant of the Shares, the Grantee shall have the right to elect: (x) to cause the full lump sum tax on the Shares under
the Authorization (whether all or part of the grant price is paid or not) as required by Applicable Laws at the time of grant to be paid
by the Company or other eligible Subject; (y) after the Company completes the IPO and releases the restriction, when the Grantee disposes
of the Shares under the Authorization, the tax on the disposed Shares shall be withheld and paid by the Company or other eligible Subject
in accordance with the requirements of the then Applicable Laws.

 

8.       Issue
of Shares

 

(a) The Shares used for authorized
issuance under this Plan have been actually issued to the Trust Platform for holding, and the Shares issued under the Authorization under
this Plan will be reflected as the right to distribute the interests of the corresponding Shares of the Trust Platform.

 

(b) Considering that the Grantee
does not actually hold the Company’s Shares issued under the Authorization, the Grantee does not have the corresponding voting rights
of the relevant Shares; the Grantee, as the beneficiary of the Trust Platform, the Company may require the Grantee to recognize and agree
not to challenge or take legal actions against the Trust.

 

     

     

    

 

9.       Termination
of Continuous Service, Loss of Authority and Right of Recovery.

 

(a) Continuous Service terminated
due to death or Disability. Unless otherwise specified by the Plan or otherwise determined by the Manager, in the event that a Grantee’s
Continuous Service terminates due to death or Disability,

 

(i)       If
the death or Disability of the Grantee is caused by work-related reason, the Grantee or the successor of the Grantee under Article 6(f)(iii)
may retain all the Shares issued under the Authorization (whether or not the Grantee’s Continuous Service with the Company or Related
Entity has been five (5) years), and disposal shall be carried out in accordance with this Plan and the Grant Agreement.

 

(ii)       If
the death or Disability of the Grantee is not caused by work-related reason, the Grantee or the successor of the Grantee under Article
6(f)(iii) may retain twenty percent (20%) of the Shares issued under the Authorization (the maximum shall not exceed one hundred percent
(100%) for each consecutive one (1) year of the Grantee’s service, and the remaining Shares shall be recovered by the Company and
the Settlor of Trust. If the Grantee has paid the grant price for the remaining Shares, the interest shall be recovered calculated as
initial price of the remaining Shares plus the annualized 4% simple interest of the initial price from the date of actual payment to the
date of payment of recovery price. If the Grantee has not paid the grant price for the remaining Shares, it shall be recovered free of
charge.

 

     

     

    

 

(b) Other Circumstances of
Termination of Continuous Service. Unless otherwise provided in the Plan or determined otherwise by the Manager, in the event that
the Grantee’s Continuous Service is terminated for any reason other than death or Disability, the Grantee may retain twenty percent
(20%) of the Shares issued under the Authorization (the maximum shall not exceed one hundred percent (100%) for each (1) year of Continuous
Service, the remaining Shares shall be recovered by the Company and the Settlor of Trust. If the Grantee has paid the grant price for
the remaining Shares, the interest shall be recovered calculated as initial price of the remaining Shares plus the annualized 4% simple
interest of the initial price from the date of actual payment to the date of payment of recovery price. If the Grantee has not paid the
grant price for the remaining Shares, it shall be recovered free of charge.

 

(c) Payment of Repurchase
Price. Among the aforesaid recovery prices:

 

(i)       Before
the Company completes the IPO (x) the part below or equal to the initial price shall be actually paid by the Settlor of Trust to the Grantee;
(y) the part exceeding the initial price shall be actually paid by the Company to the Grantee;

 

(ii)       on
and after the date on which Company completes the IPO, the recovery price shall be actually paid by the Settlor of Trust to the Grantee,
but if it is still in the lock-up period, the actual payment of the recovery price will be completed by the Settlor of Trust [within five
(5) working days].

 

(d) If the identity of the Grantee
changes between the specific positions corresponding to the eligible incentive parties, the Continuous Service shall not be regarded as
interrupted or terminated, and the Authorization shall remain valid unless otherwise determined by the Manager. If the identity of the
Grantee is changed to another identity that does not meet the Authorization qualification conditions, the Authorization and the Shares
issued thereunder shall remain valid only provided that the Manager confirms that the new identity status does not affect the Authorization,
otherwise, it will be deemed that the Continuous Service is terminated, and it shall be dealt with in accordance with Articles 9(a) and
(b) above depending on the reasons for the change of status.

 

     

     

    

 

(e) Loss of Authorization.
In the event of any of the following circumstances (each of which constitutes a “Major Violation”) during the Continuous Service
of the Grantee, whether or not the Continuous Service of the Grantee is terminated due to such circumstances, all Shares issued by the
Grantee under the Authorization shall be recovered immediately by the Settlor of Trust at the initial price:

 

(i)        The
Grantee violates the provisions of non-competition agreement, non-solicitation agreement or agreement with similar substance entered into
with the Company or Related Entity;

 

(ii)       the
Grantee violates the provisions of confidentiality agreement or obligation, intellectual property agreement or agreement with similar
substance entered into with the Company or Related Entity;

 

(iii)      the
Grantee violates the labor contract entered into with the Company or Related Entity, various rules and regulations, or policies and regulations
of the Company or Related Entity, and thus causes significant economic losses to the Company or Related Entity;

 

     

     

    

 

(iv)      the
Grantee seriously violates the duty of loyalty, or conducts dereliction of duty, misconduct of duty or malpractice, and thus causes significant
damage to the Company or Related Entity;

 

(v)       the
Grantee accepts bribes, solicits bribes, embezzles, steals, embezzles the property of the Company or Related Entity, etc., which damages
the interests and reputation of the Company or Related Entity, or conducts other acts of dishonesty, fraud, or breach of Trust, which
cause losses to the Company or Related Entity;

 

(vi)      the
Grantee defames, slanders, spreads rumors that are unfavorable to the Company or Related Entity, etc., which has a bad influence on the
Company or Related Entity;

 

(vii)     the
Grantee has violated criminal law or violated civil law by virtue of his official conduct (excluding less serious acts such as violations
of traffic laws);

 

(viii)    in
case that the Grantee is a senior executive, the Grantee’s annual performance for two (2) consecutive years after the Authorization
is obtained is at Level C or below;

 

(ix)      in
case that the Grantee is a senior executive, the Grantee fails in the annual duty reporting for two (2) consecutive years after obtaining
the Authorization;

 

(x)       other
circumstances that adversely or negatively affect the Company or Related Entity as agreed by the Manager.

 

     

     

    

 

If, after the Grantee’s
Continuous Service has been terminated not due to a Major Violation, the Grantee is determined to have committed a Major Violation during
the Continuous Service, in case that the Grantee or his/her successor retains any part of the Authorization or Shares pursuant to Article
9(a) and (b) at that time, all such retained Authorization and Shares shall be immediately recovered by the Settlor of Trust at the initial
price.

 

(f) Recovery. If the
Company and the Settlor of Trust withdraw all or part of the Authorization or the Shares under this Plan, the Manager shall have the right
to directly instruct the Settlor of Trust to instruct the Trust Platform and its related Trusts to change the beneficiary Shares or the
list of beneficiaries without Grantee’s cooperation in signing any further documents.

 

10.       Adjustment
after Capital Change. Subject to the required corporate shareholder procedures, the number of Shares corresponding to each
Authorization issued, the number of Shares authorized to issue under the Plan, for which however the corresponding Authorization has
not been granted, or which has been withdrawn into the Plan, the grant price of the Authorization issued, and any other conditions
the Manager deems necessary to be adjusted, will be adjusted proportionally as follows: (i) the increase or decrease in the number
of Shares issued, which has been made due to stock split, reverse stock split, Share dividend, Share consolidation or
reclassification, or similar transactions affecting the Share; (ii) any other increase or decrease in the number of Shares issued,
which has been carried out without consideration received; or (iii) other transactions related to the ordinary Shares determined at
the discretion of the Manager, including establishment of new company or merger, merger by absorption, acquisition of assets or
equity interests, division (including spin-offs or other distributions of shares or property), reorganizations, liquidations
(whether in part or in whole), or other similar transactions; however, the conversion of the Company’s convertible securities
shall not be deemed as a transaction “which has been carried out without consideration received”. The aforesaid
adjustments shall be made by the Manager and his decision shall be final, binding and conclusive. Unless otherwise determined by the
Manager, the issuance of Shares of any type or securities convertible into Shares of any type in the Company shall not affect nor
adjust the number or price of Shares under the Authorization. In the event of a spin-off transaction, the Manager shall have the
right to make such adjustments or other actions it deems appropriate to the Authorizations issued under the Plan at its sole
discretion, including but not limited to: (i) adjusting the number, type of the Shares, the exercise or purchase price of each Share
and the conditions for the disposal of the Shares under the issued Authorization, or (ii) the replacement, exchange or authorization
to purchase securities of the subsidiary; however, the Manager shall not be obligated to make or taken any of the aforesaid
adjustments or actions.

 

     

     

    

 

11.       Entire
Company Sale and Change of Control

 

(a)       Entire
Company Sale. Unless otherwise provided in a separate Grant Agreement or other written agreement between the Company and the Grantee,
in case of an Entire Company Sale (excluding an Entire Company Sale that is also a Change of Control), each Authorization may be Inherited
and Superseded before the effective date of the Entire Company Sale; for the part of the Authorization that is not Inherited or Superseded,
if the Continuous Service of the Grantee with the Company is not terminated before the specific effective date of the Entire Company Sale,
any right of repurchase or forfeiture or other restrictions on Shares under the Authorization shall be automatically and fully released
before the effective date.

 

(b)       Change
of Control. Unless otherwise provided in a separate Grant Agreement or other written agreement between the Company and the
Grantee, in case of a Change of Control (excluding a Change of Control that is also an Entire Company Sale), if the Grantee’s
Continuous Service with the Company is not terminated before the specific effective date of the Change of Control of the Company,
for each Authorization issued under the Plan, any right of repurchase or forfeiture or other restrictions on Shares under the
Authorization shall be automatically and fully released before the effective date.

 

     

     

    

 

(c)       Termination
of the non-Inherited and Superseded portion of Authorization in the Entire Company Sale. Upon the effective completion of the Entire
Sale, all Authorizations issued under the Plan shall terminate, but all portions of the Entire Sale that have been Inherited or Superseded
shall not terminate.

 

(d)       Other
Mechanisms. Except as otherwise provided in a separate Grant Agreement or other written agreement between the Company and the Grantee,
subject to the provisions of Applicable Laws, in case of an Entire Company Sale or a Change of Control, the Manager may make other mechanisms,
such as terminating any Authorization and withdrawing the Authorization in cash based on the value of the Shares at the time of the Entire
Company Sale or Change of Control (as the case may be).

 

(e)       Participation
in Transactions. Unless otherwise requested by the counterparty to the transaction of the Entire Company Sale or Change of Control,
the Trust Platform will participate in the relevant transaction in proportion jointly with Jie&Hao Holding Limited controlled by Shen
Ziyu and Minghao Group Limited controlled by Li Shufu.

 

12.       Effective
Date and Duration of Plan. The Plan shall take effect on the date of approval by the Board of Directors of the Company, and if
it is subject to the approval of the Company’s Shareholders in accordance with Applicable Laws before it takes effect, the
Plan shall take effect on the date of approval by the Company’s Board of Directors or the Board of Shareholders, whichever is
later (the “Effective Date”). Subject to Applicable Laws, Authorization may be granted after the Plan becomes effective.
Unless terminated earlier, the Plan will be valid for ten (10) years from the Effective Date (“Plan Validity”) and no
further Authorizations may be made under the Plan after the Plan expires. Any issued Authorizations shall remain in effect in
accordance with the terms of the Plan and the applicable Grant Agreement until the expiry of the Plan Validity.

 

     

     

    

 

13.       Amendment,
Suspension and Termination of the Plan

 

(a) Any amendments to the Plan
by the Manager (including amendment to the Validity of the Plan), suspension and termination shall be approved by the Board of Directors,
provided, however, that such amendment, suspension or termination shall be subject to the approval of the Company’s shareholders
if required by Applicable Laws, or if the amendment involves any content of Article 4(b)(vi) or 13(a) of the Plan, no amendment shall
be made accordingly without the approval of the shareholders of the Company.

 

(b) No Authorization may be
made during the suspension of plan or after the termination of plan.

 

(c) Except as determined in
good faith by the Manager, any suspension or termination of the Plan (including termination of the Plan pursuant to Article 11) shall
not materially adversely affect any rights that have been granted to Grantee.

 

14.       Reservation
of Share. During the validity of the Plan, the Company shall always ensure that the Trust Platform holds sufficient Shares to ensure
that the needs of the Plan are satisfied.

 

15.       No
Impact on Employment Relationship Terms. This Plan does not confer any rights to the Grantee in relation to continued employment,
nor does it affect the right of the Grantee, or the Company or Related Entity, to terminate the Grantee’s continued employment at
any time.

 

     

     

    

 

16.       No
Impact on Retirement and Other Benefit Plans. Unless expressly agreed otherwise in the Company’s or the Related Entity’s
retirement plan or other benefit plan, Authorization shall not be deemed compensation in the calculation of earnings or contributions
to any of the Company’s or Related Entity’s retirement plans, and shall not affect any other type of benefit plans, or the
benefit under any benefit plan established thereafter, under which an amount of available benefit is related to the salary level. Notwithstanding
the foregoing provisions, unless otherwise determined by the Manager, the Grantees who have obtained Authorization under this Plan will
no longer participate in other equity or option incentive plans of the Company.

 

17.       No
Reward Rights. No person eligible to participate in the Plan may unilaterally assert rights authorized under the Plan, and the Company
or the Manager is not obliged to treat all persons eligible to participate in the Plan in a consistent manner.

 

18.       No
Shareholder Rights. All Authorizations made under this Plan do not grant the rights of the Grantee to any shareholder of the Company.

 

19.       IPO.
At the IPO of Shares, the Grantee shall agree that the Trust Platform signs all agreements with any underwriters, coordinators,
bankers or sponsors appointed by the Company for the purpose of the IPO. To this end, the Grantee shall confirm that the Trust
Platform has the right to sign on its own behalf, or authorize the Board of Directors or other Subjects designated by the Board of
Directors sign on behalf of the Trust Platform, all agreements with any underwriters, coordinators, bankers or sponsors appointed by
the Company for the purpose of completing the IPO, and to take all necessary and appropriate actions and sign all necessary and
appropriate documents.

 

20.       No
Financial Preparation Obligations. Regardless of the purpose, the Company or the Trust Platform has no obligation to reserve funds
or to mortgage with regard to the payables to the Grantee under this Plan. Neither the Company nor the Trust Platform will be required
to segregate any amounts from its general funds or establish any Trust or any special account for such obligation. Any investment by the
Company or Trust Platform, or any establishment or maintenance of a Trust or the Grantee’s account, will not constitute a fiduciary
or loyal relationship between the Manager, the Company or Trust Platform and the Grantee, nor will any encashment or beneficial rights
of the Grantee or the Grantee’s creditors in the assets of the Company or Trust Platform. Regardless of any changes in the value
of any assets invested or reinvested by the Company or Trust Platform based on this Plan, the Grantee shall have no right to make any
claims against the Company or Trust Platform.

 

21.       Entire
Plan. This Plan, the separate Grant Agreement, the grant notice, together with all Exhibits, are restatements and amendments to the
2019 Restrictive Share Incentive Plan (Trust) (the “Original Incentive Plan”) adopted in December 6, 2019, constitute and
become the entire Restrictive Share Incentive Plan and the Parties’ entire understanding of the matters referred to herein, supersede
any or all prior negotiations, correspondences, agreements, understandings, memorandums, responsibilities or obligations between the Parties
on the relevant matters, and shall supersede and replace the Original Inventive Plan in all respects from the date this Plan being effective.

 

22.       Interpretation.
Headings in this Plan are for convenience only and shall not affect any meaning or interpretation of the terms of this Plan. The use of
 “or” is not intended to be exclusive, unless otherwise expressly indicated in the context.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]